Financial News
Articles published by Gilead Sciences, Inc.
![](https://mms.businesswire.com/media/20220211005569/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve Adults
February 11, 2022
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220211005143/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220207006025/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs
February 08, 2022
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220202005999/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
February 03, 2022
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220131005840/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220128005546/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220131005477/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20220121005359/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220116005036/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022
January 18, 2022
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20220107005485/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211221005805/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211221005769/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211220005841/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Present at Upcoming Investor Conference
December 21, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20211216006213/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211216006041/en/1309610/5/DS_Logo.jpg)
![](https://mms.businesswire.com/media/20211213005875/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20211211005053/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20211211005050/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20211211005047/en/935449/5/ZUMA-7_Global_Clinical_Trial_Sites_Map.jpg)
![](https://mms.businesswire.com/media/20211210005006/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211129005037/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211123005779/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211119005269/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20211118005065/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Present at Upcoming Investor Conference
November 18, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20211118005582/en/928713/4/Arcus_Logo.jpg)
![](https://mms.businesswire.com/media/20211110006163/en/925878/4/Everest_Medicines_Logo.jpg)
![](https://mms.businesswire.com/media/20211109005632/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead to Present Data From Liver Disease Development Programs at The Liver Meeting®
November 09, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20211104005797/en/923679/5/GileadKite_horizontal_color.jpg)
Gilead and Kite Oncology Demonstrate Broad Leadership in Cell Therapy and Expanding Blood Cancer Pipeline
November 04, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20211029005237/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.